Diabetes Board decisions

The Board has granted service connection for PTSD, right ear hearing loss, and tinnitus. Service connection was also granted for diabetes mellitus Type 2 as secondary to exposure to Agent Orange. The veteran's hypertension is not service connected.

The veteran's service-connected disabilities, including PTSD and multiple knee issues, render him unable to work in other than marginal or part-time employment.

The Board has granted service connection for the cause of the veteran's death due to Type II diabetes mellitus, which was presumed to have been caused by his in-service exposure to Agent Orange. The renal disease that led to his death is considered more than likely due to this diabetes.

The Board has determined that the veteran's diabetes mellitus was not incurred or aggravated by service and denied his claim for service connection.

The Board has determined that the veteran does not have diabetes mellitus that is attributable to his active military service and therefore denied the claim for service connection.

The Board has determined that the veteran's chronic upper respiratory disability is not related to active service and therefore denied his claim for service connection.

The veteran's claim for a higher initial evaluation for type II diabetes mellitus associated with herbicide exposure was denied, and his service connection claim for residuals of Agent Orange exposure to include headaches, vision problems, dizziness, leg and foot cramps, sore muscles, and chest pains was also denied.

The Board has determined that there is no medical evidence linking the veteran's jungle rot of the feet to his period of active service. The claims for diabetes, diabetic neuropathy, heart disease, and hypertension are also denied as secondary to diabetes.

The veteran is granted a 100% rating for diabetic retinopathy effective November 24, 2000.

The Board has determined that there is no evidence of a current diagnosis of diabetes, type II and the veteran's service connection claims for diabetes, types I and II are denied.

The Board has determined that the veteran's type II diabetes mellitus and prostate cancer are not service-connected due to herbicide exposure in Vietnam. The duodenal ulcer disease claim is granted with restoration of a 20 percent rating.

The Board has determined that the veteran's ulcerative colitis, status-post colectomy and ileostomy does not meet or approximate the criteria for a rating in excess of 60 percent.

The Board has remanded the case for further development, including a VA examination and proper VCAA notice.

The Board has granted service connection for Type II diabetes mellitus as due to herbicide exposure. The claims for hypertension, peripheral neuropathy, and erectile dysfunction are pending and require further examination.

The veteran's appeal is being remanded for additional development, including obtaining medical records and scheduling a VA examination to assess the severity of his diabetes mellitus and determine if hypertension and depression are secondary to service-connected diabetes.

The Board has determined that the veteran's service-connected diabetes mellitus warrants a 20 percent rating, and his initial hearing loss disability is not compensable.

The veteran's claim for an increased rating for diabetes mellitus associated with herbicide exposure is being remanded due to the need for additional medical examination and treatment records.

The veteran withdrew his appeal seeking service connection for diabetes mellitus (type II) due to herbicide exposure, and the Board has dismissed the appeal.

The veteran's claims for diabetes mellitus and cirrhosis of the liver were denied as they are not shown to be related to service. The claim for increased evaluation for residuals of a low back injury was also denied, but only prior to September 26, 2003. The claim for compensable evaluation for calluses of the feet was denied and the TDIU claim was also denied.

The Board has remanded the case due to incomplete information regarding the veteran's periods of active service, ACDUTRA and INACDUTRA. The claim will be readjudicated after obtaining the necessary medical records.